HomeCTKB • NASDAQ
add
Cytek Biosciences Inc
Previous close
$6.50
Day range
$6.46 - $6.61
Year range
$4.66 - $9.87
Market cap
825.68M USD
Avg Volume
773.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 51.50M | 7.29% |
Operating expense | 33.25M | -1.03% |
Net income | 941.00K | 114.58% |
Net profit margin | 1.83 | 113.61% |
Earnings per share | 0.06 | 1,194.12% |
EBITDA | -2.40M | 48.48% |
Effective tax rate | -499.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 277.78M | -3.56% |
Total assets | 491.23M | -5.43% |
Total liabilities | 105.76M | 1.79% |
Total equity | 385.46M | — |
Shares outstanding | 128.81M | — |
Price to book | 2.19 | — |
Return on assets | -2.18% | — |
Return on capital | -2.65% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 941.00K | 114.58% |
Cash from operations | 13.22M | 411.89% |
Cash from investing | -15.81M | -136.66% |
Cash from financing | -12.08M | -46.05% |
Net change in cash | -15.62M | -148.67% |
Free cash flow | 9.81M | 1,723.76% |
About
Founded
1992
Website
Employees
645
